Active HCV infection worsens the prognosis of very early-stage HCC after ablation therapyMarch 21, 2022Hepatocellular Carcinoma
Risk factors for recurrence after hepatic resection for early-stage HCCMarch 21, 2022Hepatocellular Carcinoma
Inadequate ultrasound quality negatively influences HCC surveillance test performanceMarch 21, 2022Hepatocellular Carcinoma
MRE-based shear strain mapping may preoperatively predict microvascular invasion in HCCMarch 21, 2022Hepatocellular Carcinoma
Ramucirumab-mediated survival benefit in advanced HCC unperturbed by baseline prognostic covariatesMarch 21, 2022Hepatocellular Carcinoma
Meta-analysis underscores the need for improved HCC surveillance in NAFLD without cirrhosisMarch 21, 2022Hepatocellular Carcinoma
LEN-TACE sequential therapy tops LEN monotherapy in unresectable HCC responsive to initial LEN treatmentMarch 21, 2022Hepatocellular Carcinoma
Final phase 2 results testify to the clinical advantage of TACE plus sorafenib in unresectable HCCMarch 21, 2022Hepatocellular Carcinoma
Overall survival after curative resection for HBV-related HCC is better with tenofovir vs. entecavirMarch 21, 2022Hepatocellular Carcinoma
Old age and liver stiffness on transient elastography may predict HCC occurrence after HCV eradicationFebruary 22, 2022Hepatocellular Carcinoma
Liver resection in HCC: Robot-assisted and laparoscopic vs. openFebruary 22, 2022Hepatocellular Carcinoma
Tenofovir disoproxil fumarate vs. entecavir: Curtailing the risk of chronic hepatitis B-induced HCCFebruary 22, 2022Hepatocellular Carcinoma
Sorafenib plus HAIC a favorable therapeutic option for HCC with major portal vein tumor thrombosisFebruary 22, 2022Hepatocellular Carcinoma
Posthepatectomy antiviral therapy boosts survival outcomes in HBV-related HCCFebruary 22, 2022Hepatocellular Carcinoma
